$45.9 Billion is the total value of ADAGE CAPITAL PARTNERS GP, L.L.C.'s 801 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XENE | XENON PHARMACEUTICALS INC | $37,681,000 | +38.9% | 2,450,000 | 0.0% | 0.08% | +20.6% | |
ARDX | ARDELYX INC | $32,350,000 | +23.2% | 5,000,000 | 0.0% | 0.07% | +7.6% | |
ERES | EAST RES ACQUISITION CO | $27,913,000 | +4.3% | 2,750,000 | 0.0% | 0.06% | -9.0% | |
AGLE | AEGLEA BIOTHERAPEUTICS INC | $23,547,000 | +11.0% | 2,992,000 | 0.0% | 0.05% | -3.8% | |
CRHCU | COHN ROBBINS HOLDINGS CORPunit 08/11/2025 | $21,500,000 | +6.5% | 2,000,000 | 0.0% | 0.05% | -7.8% | |
HZACU | HORIZON ACQUISITION CORPunit 99/99/9999 | $21,120,000 | +1.5% | 2,000,000 | 0.0% | 0.05% | -11.5% | |
PRQR | PROQR THRAPEUTICS N V | $19,110,000 | -12.3% | 4,550,062 | 0.0% | 0.04% | -23.6% | |
MARINUS PHARMACEUTICALS INC | $17,843,000 | -5.1% | 1,462,500 | 0.0% | 0.04% | -17.0% | ||
ALUS | ALUSSA ENERGY ACQUISITION CO | $18,108,000 | +1.3% | 1,800,000 | 0.0% | 0.04% | -13.3% | |
PEAK | HEALTHPEAK PROPERTIES INC | $17,644,000 | +11.3% | 583,643 | 0.0% | 0.04% | -5.0% | |
GRTX | GALERA THERAPEUTICS INC | $15,442,000 | +13.2% | 1,509,500 | 0.0% | 0.03% | 0.0% | |
QURE | UNIQURE NV | $12,646,000 | -1.9% | 350,000 | 0.0% | 0.03% | -12.5% | |
FSDC | FS DEV CORP | $11,000,000 | -1.8% | 1,000,000 | 0.0% | 0.02% | -14.3% | |
CRWD | CROWDSTRIKE HLDGS INCcl a | $10,591,000 | +54.3% | 50,000 | 0.0% | 0.02% | +35.3% | |
HSAQ | HEALTH SCIENCES ACQ CORP 2 | $10,248,000 | +16.5% | 800,000 | 0.0% | 0.02% | 0.0% | |
ORTX | ORCHARD THERAPEUTICS PLCads | $8,640,000 | +5.1% | 2,000,000 | 0.0% | 0.02% | -9.5% | |
AUPH | AURINIA PHARMACEUTICALS INC | $8,618,000 | -6.1% | 623,110 | 0.0% | 0.02% | -17.4% | |
CBAY | CYMABAY THERAPEUTICS INC | $8,323,000 | -20.7% | 1,450,000 | 0.0% | 0.02% | -30.8% | |
KIN | KINDRED BIOSCIENCES INC | $7,219,000 | +0.5% | 1,675,000 | 0.0% | 0.02% | -11.1% | |
BCTG | BCTG ACQUISITION CORP | $6,864,000 | +10.4% | 600,000 | 0.0% | 0.02% | -6.2% | |
RCUS | ARCUS BIOSCIENCES INC | $6,490,000 | +51.5% | 250,000 | 0.0% | 0.01% | +27.3% | |
OTIC | OTONOMY INC | $6,635,000 | +59.8% | 1,025,500 | 0.0% | 0.01% | +40.0% | |
TIG | TREAN INS GROUP INC | $5,240,000 | -14.1% | 400,000 | 0.0% | 0.01% | -26.7% | |
FARM | FARMER BROS CO | $4,061,000 | +5.6% | 869,699 | 0.0% | 0.01% | -10.0% | |
CFRX | CONTRAFECT CORP | $3,283,000 | -4.3% | 650,000 | 0.0% | 0.01% | -22.2% | |
FI | FRANKS INTL N V | $2,414,000 | +77.9% | 880,846 | 0.0% | 0.01% | +66.7% | |
NLY | ANNALY CAPITAL MANAGEMENT IN | $1,690,000 | +18.7% | 200,000 | 0.0% | 0.00% | 0.0% | |
OII | OCEANEERING INTL INC | $1,193,000 | +125.9% | 150,000 | 0.0% | 0.00% | +200.0% | |
CHENIERE ENERGY INCnote 4.250% 3/1 | $1,174,000 | +8.1% | 1,500,000 | 0.0% | 0.00% | 0.0% | ||
ERESW | EAST RES ACQUISITION CO*w exp 07/01/202 | $1,568,000 | +78.2% | 1,375,000 | 0.0% | 0.00% | +50.0% | |
CUB | CUBIC CORP | $871,000 | +6.7% | 14,036 | 0.0% | 0.00% | 0.0% | |
ALUSWS | ALUSSA ENERGY ACQUISITION CO*w exp 10/31/202 | $1,107,000 | +89.2% | 900,000 | 0.0% | 0.00% | +100.0% | |
PANAWS | PANACEA ACQUISITION CORP*w exp 07/07/202 | $853,000 | +36.0% | 266,666 | 0.0% | 0.00% | 0.0% | |
ARNC | ARCONIC CORPORATION | $1,118,000 | +56.6% | 37,500 | 0.0% | 0.00% | 0.0% | |
CMTL | COMTECH TELECOMMUNICATIONS C | $383,000 | +47.9% | 18,499 | 0.0% | 0.00% | 0.0% | |
MOGA | MOOG INCcl a | $599,000 | +24.8% | 7,553 | 0.0% | 0.00% | 0.0% | |
SNDL | SUNDIAL GROWERS INC | $426,000 | +96.3% | 900,000 | 0.0% | 0.00% | 0.0% | |
ZSAN | ZOSANO PHARMA CORP | $527,000 | -67.5% | 1,000,000 | 0.0% | 0.00% | -75.0% | |
SVRA | SAVARA INC | $460,000 | +5.5% | 400,000 | 0.0% | 0.00% | 0.0% | |
BAK | BRASKEM S Asp adr pfd a | $135,000 | +20.5% | 14,940 | 0.0% | 0.00% | – | |
SPKE | SPARK ENERGY INC | $129,000 | +15.2% | 13,474 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLE INC | 43 | Q3 2023 | 6.0% |
MICROSOFT CORP | 43 | Q3 2023 | 5.5% |
AMAZON COM INC | 43 | Q3 2023 | 4.0% |
BERKSHIRE HATHAWAY INC DEL | 43 | Q3 2023 | 1.3% |
JPMORGAN CHASE & CO | 43 | Q3 2023 | 1.3% |
EXXON MOBIL CORP | 43 | Q3 2023 | 1.6% |
JOHNSON & JOHNSON | 43 | Q3 2023 | 1.2% |
PROCTER & GAMBLE CO | 43 | Q3 2023 | 1.0% |
WELLS FARGO CO NEW | 43 | Q3 2023 | 1.6% |
UNITEDHEALTH GROUP INC | 43 | Q3 2023 | 1.2% |
View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CymaBay Therapeutics, Inc. | September 11, 2023 | 3,685,625 | 3.8% |
Verastem, Inc. | August 31, 2023 | 1,300,000 | 5.2% |
Molecular Templates, Inc. | July 18, 2023 | 4,391,489 | 5.4% |
ABEONA THERAPEUTICS INC. | July 06, 2023 | 3,249,994 | 15.3% |
Praxis Precision Medicines, Inc. | June 30, 2023 | 7,930,638 | 6.2% |
REATA PHARMACEUTICALS INC | June 26, 2023 | 1,730,841 | 5.2% |
Provention Bio, Inc. | February 21, 2023 | 5,398,825 | 6.0% |
ADAMS NATURAL RESOURCES FUND, INC. | February 09, 2023 | 1,308,791 | 5.4% |
Akili, Inc.Sold out | February 09, 2023 | 0 | 0.0% |
Ambrx Biopharma Inc. | February 09, 2023 | 7,191,037 | 2.7% |
View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-04-11 |
SC 13G | 2024-02-26 |
SC 13G | 2024-02-26 |
SC 13G | 2024-02-23 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-12 |
SC 13G/A | 2024-02-07 |
SC 13G/A | 2024-02-07 |
SC 13G/A | 2024-02-07 |
View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.